Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

BioGaia

113.40 SEK

Less than 1K followers

BIOG B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioGaia

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue304.0364.81,422.7366.3404.7326.6440.61,538.2
EBITDA99.0110.7500.1103.3114.692.1127.1437.2
EBIT41.4103.4423.497.1108.486.0121.0412.5
EBIT-%13.6 %28.3 %29.8 %26.5 %26.8 %26.3 %27.5 %26.8 %
Profit before taxes47.0104.5447.8101.9110.485.3123.6421.2
Net income36.681.9351.480.287.965.998.8332.8
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.